Additional file 8: Table S6. A total of 754 regulated DEGs (|logFC|≧0.5) selected after both overexpression and knockdown of SLCO4A1-AS1 in two independent RNA sequencing data sets.
Tyrosine kinase-activating mutations in Met have been observed in hereditary papillary renal carcinomas as well as in other cancers. These mutations have been examined in several in vitro systems, whe
AimsDeleted in liver cancer 1 (DLC1), a member of RhoGTPase activating protein (GAP) family, is known to have suppressive activities in tumorigenicity and cancer metastasis. However, the underlying mo
